» Articles » PMID: 39495390

Relationships Between Polymorphisms in HLA-G 3'UTR Region and COVID-19 Disease Severity

Overview
Journal Biochem Genet
Specialty Molecular Biology
Date 2024 Nov 4
PMID 39495390
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study is to investigate the the relationships between HLA-G gene variants and sHLA-G with susceptibility to SARS-CoV-2 infection. In this case-control study, 65 Patients with COVID-19 were and 67 healthy controls were genotyped for their main functional polymorphisms namely, the 14-bp Ins/Del (rs371194629), +3003C/T (rs1707), +3010C/G (rs1710), +3027A/C (rs17179101), +3035C/T (rs17179108), +3142C/G (rs1063320), +3187A/G (rs9380142) and +3196C/G (rs1610696) in the exon 8 of the 3' untranslated regions (3' UTRs) using sanger sequencing method. Associations were assessed for five inheritance models (codominant, dominant, recessive, over-dominant and log-additive). Moreover, the levels of plasma soluble HLA-G (sHLA-G) were explored using ELISA method. Our results revealed that the 14-bp INS/DEL polymorphism was strongly associated with COVID-19 symptoms development for almost all tested inheritance models (p < 0.001). Inversely, the (+3196C/G) polymorphism exhibited a protective effect against COVID-19. In addition, three haplotypes; UTR-1, UTR-3, and UTR-5 were found associated with COVID-19 symptoms (p < 0.05), The level of HLA-G in the serum was significantly higher in COVID-19 individuals than in healthy individuals (p < 0.001).These findings suggest that HLA-G gene polymorphisms in the regulatory 3'UTR region of the HLA-G gene may influence the host immune response to SARS-CoV-2 infection. A deeper comprehension of the functional effect of these associated polymorphisms could be useful in identifying high-risk individuals and in developing adaptive treatments for patients.

References
1.
Adhiah A, Al-Bayatee N . HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients. Hum Immunol. 2022; 83(6):521-527. PMC: 8920981. DOI: 10.1016/j.humimm.2022.03.005. View

2.
Aisagbonhi O, Morris G . Human Leukocyte Antigens in Pregnancy and Preeclampsia. Front Genet. 2022; 13:884275. PMC: 9093604. DOI: 10.3389/fgene.2022.884275. View

3.
Al-Bayatee N, Adhiah A . Soluble HLA-G is upregulated in serum of patients with severe COVID-19. Hum Immunol. 2021; 82(10):726-732. PMC: 8282477. DOI: 10.1016/j.humimm.2021.07.007. View

4.
Alcami A, Ghazal P, Yewdell J . Viruses in control of the immune system. Workshop on molecular mechanisms of immune modulation: lessons from viruses. EMBO Rep. 2002; 3(10):927-32. PMC: 1307615. DOI: 10.1093/embo-reports/kvf200. View

5.
Alyami A, AlJurayyan A, Alosaimi B, Alkadi H, Alkhulaifi F, Al-Jurayb H . The correlation between soluble human leukocyte antigen (sHLA-G) levels and +3010 polymorphism. Int J Immunogenet. 2023; 51(1):39-46. DOI: 10.1111/iji.12648. View